Tech Company Financing Transactions

3-V Biosciences Funding Round

New Enterprise Associates, Kleiner Perkins Caufield & Byers and The Column Group participated in a $30 million Series B funding round for 3-V Biosciences. The financing round was recorded on 8/6/2009.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

3715 Haven Ave. 220
Menlo Park, CA 94025
USA

Phone

(650) 561-8600

Website

www.3vbio.com

Email Address

[email protected]

Overview

3-V Biosciences is a biopharmaceutical company developing therapeutics for the treatment of infectious diseases.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

George Kemble

        

Chief Medical Officer

William McCulloch

        

Vice President

Douglas Buckley

        

Browse more venture capital transactions:

Prev: 8/6/2009: VillageEDOCS venture capital transaction
Next: 8/6/2009: Rasmussen Reports venture capital transaction

Share this article

About Our VC Transactions Data

We do our best to report on all VC transactions involving tech companies. VC transactions reported here are derived from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary